Literature DB >> 1335663

Ecology and prevention of a shellfish-associated hepatitis A epidemic in Shanghai, China.

Z Y Xu1, Z H Li, J X Wang, Z P Xiao, D X Dong.   

Abstract

During a shellfish-borne hepatitis A outbreak in Shanghai during the first quarter of 1988, 300,000 cases were reported in two months. Using cell culture and experimental infection of marmosets, hepatitis A virus (HAV) was isolated from clams collected from the market and the sea bed during the epidemic. A dose-response curve correlating the quantity of clams consumed to the attack rate of hepatitis A was well documented. The occurrence of the epidemic was associated with a good harvest of clams in a new area, serious pollution of this area with sewage and importation of the clams in large quantities into Shanghai where most young adults were susceptible. Clams can apparently be decontaminated by using a continuous water flow. In this way, HAV titres can be reduced by 90% in one day and by 99.9% in two weeks. An attenuated live HAV vaccine which has been developed in China has been shown to be safe and immunogenic and may be used for prevention of such epidemics in the future.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335663     DOI: 10.1016/0264-410x(92)90547-w

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention.

Authors:  Ameer Abutaleb; Shyam Kottilil
Journal:  Gastroenterol Clin North Am       Date:  2020-03-29       Impact factor: 3.806

2.  Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004-2010.

Authors:  Ying Hu; Chuanhua Yu; Banghua Chen; Lei Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

3.  Cost effectiveness of hepatitis A virus immunisation in Spain.

Authors:  J M Arnal; O Frisas; R Garuz; F Antoñanzas
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

Review 4.  Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®.

Authors:  Jun-Yu Wu; Yan Liu; Jiang-Ting Chen; Ming Xia; Xiao-Mei Zhang
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

Review 5.  New developments in hepatitis A control.

Authors:  L Yuan
Journal:  Can Fam Physician       Date:  1995-07       Impact factor: 3.275

6.  Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka.

Authors:  Niroshana J Dahanayaka; Tomoko Kiyohara; Suneth B Agampodi; Pradeep K Samaraweera; Gayani K Kulasooriya; Jagath C Ranasinghe; Saveen N Semage; Sayaka Yoshizaki; Takaji Wakita; Koji Ishii
Journal:  Am J Trop Med Hyg       Date:  2016-07-05       Impact factor: 2.345

Review 7.  Development, production, and postmarketing surveillance of hepatitis A vaccines in China.

Authors:  Fuqiang Cui; Xiaofeng Liang; Fuzhen Wang; Hui Zheng; Yvan J Hutin; Weizhong Yang
Journal:  J Epidemiol       Date:  2014-03-29       Impact factor: 3.211

8.  Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006.

Authors:  Zhiyuan Jia; Yao Yi; Jianhua Liu; Jingyuan Cao; Yong Zhang; Ruiguang Tian; Tao Yu; Hao Wang; Xinying Wang; Qiudong Su; Wenting Zhou; Fuqiang Cui; Xiaofeng Liang; Shengli Bi
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

9.  HAV Immunity in Iranian Medical Students.

Authors:  Seyyed Javad Hosseini Shokouh; Alireza Dadashi; Mohamad Abiri; Iraj Zohrevand; Ahad Eshraghian; Alireza Khoshdel; Behnam Heidari; Shayan Khoshkish
Journal:  Hepat Mon       Date:  2015-03-31       Impact factor: 0.660

10.  Facilities for Centralized Isolation and Quarantine for the Observation and Treatment of Patients with COVID-19: Experience from Wuhan, China.

Authors:  Xianliang Wang; Jiao Wang; Jin Shen; John S Ji; Lijun Pan; Hang Liu; Kangfeng Zhao; Li Li; Bo Ying; Lin Fan; Liubo Zhang; Lin Wang; Xiaoming Shi
Journal:  Engineering (Beijing)       Date:  2021-04-22       Impact factor: 7.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.